SVBT yields 1.58% · ABBV yields 3.06%● Live data
📍 SVBT pulled ahead of the other in Year 7
Combined, SVBT + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SVBT + ABBV for your $10,000?
SVB & T Corporation operates as a financial holding company for Springs Valley Bank & Trust Company that provides banking and financial services to individual and corporate customers in Orange, Dubois, and surrounding counties in southern Indiana. It offers checking, savings, and club accounts; certificates of deposit; individual retirement accounts; health savings accounts; CDARS/insured cash sweep accounts; and safe deposit boxes. The company also provides personal loans comprising mortgages, construction, professional loans, first time home buyer, and veteran's administration loan/federal housing administration/US department of agriculture; home equity line of credit and consumer loan products; and debit and credit cards. In addition, it offers business loans comprising commercial, agricultural, lines of credit, small business administration/farm service agency, and leases; and financial planning, investment management, estate planning and administration, trust, and other services, as well as brokerage services, such as mutual funds, annuities, tax advantage investments, life insurance products, retirement plans, and professionally managed accounts. Further, the company offers online solutions, which include online banking, e-statement, retail bill pay, mobile banking, mobile deposit, transfer, and mobile wallet services, as well as cash management services. SVB&T Corporation was founded in 1902 and is headquartered in French Lick, Indiana.
Full SVBT Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.